43E0.F electroCore, Inc.

Healthcare Medical Devices Frankfurt Exchange
6.70 EUR
Close of Nov 11, 2026
3.54 10.60
Market cap
EUR 61.8M
P/E
-
P/B
33.55x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 43E0.F undervalued?

Graham number

The Graham number of electroCore, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

electroCore, Inc. fundamental analysis

No fundamental analysis for electroCore, Inc. yet.

electroCore, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About electroCore, Inc.

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and parox…

Full company profile